conivaptan has been researched along with vinblastine in 2 studies
| Studies (conivaptan) | Trials (conivaptan) | Recent Studies (post-2010) (conivaptan) | Studies (vinblastine) | Trials (vinblastine) | Recent Studies (post-2010) (vinblastine) |
|---|---|---|---|---|---|
| 188 | 17 | 64 | 243 | 0 | 77 |
| Protein | Taxonomy | conivaptan (IC50) | vinblastine (IC50) |
|---|---|---|---|
| Tubulin alpha-1A chain | Sus scrofa (pig) | 1.1 | |
| Tubulin beta chain | Sus scrofa (pig) | 1.1 | |
| Tubulin beta-4A chain | Homo sapiens (human) | 0.8233 | |
| Cholinesterase | Homo sapiens (human) | 2.1 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 8 | |
| Tubulin beta chain | Homo sapiens (human) | 0.8233 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 6 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 0.8233 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.6 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 5.037 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.1 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 2.1 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.1 | |
| Thromboxane-A synthase | Homo sapiens (human) | 1.87 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 0.8233 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 0.8233 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 0.8233 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 0.8233 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 0.8233 | |
| Beta-tubulin | Leishmania donovani | 1 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 0.8233 | |
| Tubulin beta-2B chain | Bos taurus (cattle) | 0.65 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 0.8233 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 0.8233 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 0.65 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 0.65 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 0.8233 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 0.8233 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 0.8233 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 0.8233 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
2 other study(ies) available for conivaptan and vinblastine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |